JPM24: After 'clearing the decks,' Alkermes ready to roll as pure-play neuroscience company

Age 37 might be old for a “coming-out party,” but that’s the situation for Alkermes at this year’s J.P. Morgan Healthcare Conference, chief operating officer Blair Jackson said in an interview.

After the most transformational year the history of the Dublin, Ireland, drugmaker, Alkermes is stripped down and anxious to carry on in its new role as a pure-play neuroscience specialist.